Manjunath, M.; Swaroop, S.; Pradhan, S.S.; Rao K, R.; Mahadeva, R.; Sivaramakrishnan, V.; Choudhary, B.
Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor. Genes 2022, 13, 1208.
https://doi.org/10.3390/genes13071208
AMA Style
Manjunath M, Swaroop S, Pradhan SS, Rao K R, Mahadeva R, Sivaramakrishnan V, Choudhary B.
Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor. Genes. 2022; 13(7):1208.
https://doi.org/10.3390/genes13071208
Chicago/Turabian Style
Manjunath, Meghana, Sai Swaroop, Sai Sanwid Pradhan, Raksha Rao K, Raghunandan Mahadeva, Venketesh Sivaramakrishnan, and Bibha Choudhary.
2022. "Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor" Genes 13, no. 7: 1208.
https://doi.org/10.3390/genes13071208
APA Style
Manjunath, M., Swaroop, S., Pradhan, S. S., Rao K, R., Mahadeva, R., Sivaramakrishnan, V., & Choudhary, B.
(2022). Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor. Genes, 13(7), 1208.
https://doi.org/10.3390/genes13071208